OXFORD IMMUNOTEC GLOBAL LIMITED
Get an alert when OXFORD IMMUNOTEC GLOBAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-29
Confirmation statement due
2026-08-28 (in 3mo)
Last made up 2025-08-14
Watchouts
None on the register
Cash
£706
-5.4% vs 2023
Net assets
£144K
-30.1% vs 2023
Employees
0
Average over period
Profit before tax
-£62K
-14,328.4% vs 2023
Name history
Renamed 1 time since incorporation
- OXFORD IMMUNOTEC GLOBAL LIMITED 2021-03-17 → present
- OXFORD IMMUNOTEC GLOBAL PLC 2013-08-16 → 2021-03-17
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2023-12-31
Latest accounts filed cover 2024-12-29; financial figures currently reflect up to 2023-12-31.
| Metric | Trend | 2023-01-01 | 2023-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£199 | -£2,284 | |
| Profit before tax | £436 | -£62,036 | |
| Net profit | — | — | |
| Cash | £746 | £706 | |
| Total assets less current liabilities | £206,136 | £144,098 | |
| Net assets | £206,108 | £144,070 | |
| Equity | £206,108 | £144,070 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-01-01 | 2023-12-31 |
|---|---|---|---|
| Return on capital employed | -0.1% | -1.6% | |
| Interest cover | -0.55x | -0.04x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Having taken into account the above factors, including the re-organisation as discussed in Note 5 "Investments" our directors have a reasonable expectation that we have adequate resources to continue in businessat least 12 months from the date of the financial statements. Accordingly, the financial statements have been prepared on the going concern basis.”
Group structure
- OXFORD IMMUNOTEC GLOBAL LIMITED · parent
- Oxford Immunotec Limited 100%
- Oxford Immunotec USA Inc. 100%
- Immunetics, Inc. 100%
- Oxford Immunotec K.K. 100%
- Boulder Diagnostic Europe GmbH 100%
- Oxford Immunotec Asia Limited 100%
- Oxford Immunotec (Shanghai) Medical Device Co. Ltd. 100%
- Oxford Immunotec (Ireland) Limited 100%
- Oxford Diagnostic Laboratories (UK) Limited 100%
Significant events
- “There have been no significant events after the reporting period that would require disclosure.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 19 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GOLDBERG, Joel | Director | 2021-03-08 | Feb 1969 | American |
| HART, Steven Christopher | Director | 2024-01-18 | Apr 1975 | British |
Show 19 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| KEILEY, Elizabeth | Secretary | 2013-08-16 | 2019-04-12 |
| KIDD, Janet Louise, Ms. | Secretary | 2019-11-18 | 2021-03-17 |
| MCLAUGHLIN, Matthew Thomas Edward | Secretary | 2019-04-13 | 2019-11-17 |
| ANDREWS, Ronald | Director | 2015-11-04 | 2021-03-08 |
| BALTHROP, SR., Patrick | Director | 2016-01-29 | 2021-03-08 |
| KEEFE, Phillip Anthony | Director | 2022-05-27 | 2024-01-18 |
| KLAUSNER, Mark | Director | 2018-03-01 | 2021-03-08 |
| LATHI, Vijay | Director | 2013-08-22 | 2014-06-12 |
| PITCHFORD, Nigel Aaron, Dr | Director | 2013-08-22 | 2015-06-09 |
| RANDALL, Patricia, Ms. | Director | 2014-06-12 | 2021-03-08 |
| ROSENMAN, Herman | Director | 2013-10-30 | 2021-03-08 |
| SANDBERG, Richard Alvin | Director | 2013-08-16 | 2021-03-08 |
| SPOTTS, Steve Liles | Director | 2013-08-22 | 2018-06-19 |
| STEINMETZ, Ludwig Michael | Director | 2013-08-22 | 2014-06-12 |
| STROHMENGER, Rainer Herbert, Dr | Director | 2013-08-22 | 2013-11-27 |
| TOBIN, James, Mr. | Director | 2014-12-01 | 2021-03-08 |
| WALTON, Andrew Scott | Director | 2015-11-04 | 2021-03-08 |
| WRIGHTON-SMITH, Peter James | Director | 2013-08-16 | 2022-05-27 |
| NEW MEDIA SPARK DIRECTORS LIMITED | Corporate Director | 2013-08-22 | 2013-11-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Revvity (Uk) Holdings Limited | Corporate entity | Shares 75–100% | 2021-03-07 | Active |
Filing timeline
Last 20 of 157 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-07 | AA | accounts | Accounts with accounts type full | |
| 2025-09-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-07 | AAMD | accounts | Accounts amended with accounts type full | |
| 2025-02-27 | AA | accounts | Accounts with accounts type total exemption full | |
| 2024-11-05 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-10-10 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-10-10 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-10-10 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-10-10 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-08-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-02-15 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-02-06 | AA | accounts | Accounts with accounts type full | |
| 2024-01-18 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-18 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-06 | AA | accounts | Accounts with accounts type full | |
| 2022-08-19 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-08-19 | AD04 | address | Move registers to registered office company with new address | |
| 2022-06-20 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-06-13 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2023 · period ending 2023-12-31 vs 2023-01-01
-
Turnover
—
Not reported
-
Cash
-5.4%
£746 £706
-
Net assets
-30.1%
£206,108 £144,070
-
Employees
—
Not reported
-
Operating profit
-1,047.7%
-£199 -£2,284
-
Profit before tax
-14,328.4%
£436 -£62,036
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers